Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer. [electronic resource]
Producer: 20000523Description: 31-8 p. digitalISSN:- 1525-8165
- Adult
- Antigens, CD34 -- blood
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Blood Transfusion
- Breast Neoplasms -- mortality
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Epirubicin -- administration & dosage
- Female
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hematopoietic Stem Cell Mobilization
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Hospitalization
- Humans
- Leukapheresis
- Leukopenia -- etiology
- Middle Aged
- Platelet Transfusion
- Salvage Therapy -- adverse effects
- Stem Cells
- Thrombocytopenia -- etiology
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.